Identification and synthesis of novel medicinal chemistry relevant heterocycles

用高通量片段筛选（例如XChem方法）取代药物靶点的高通量生化筛选，然后采用增强的计算方法来优化片段命中先导物，可以加速项目并降低成本和对大型化合物文库的需求。为了实现这一高质量的片段库覆盖广泛的化学空间必须开发。幸运的是，数千种可能与药物化学相关的杂环化合物尚未被报道，这些杂环化合物将丰富片段筛选集并成为药物化学运动的有用构建块。这些新的杂环化合物、可行合成路线的知识和新的合成方法的建立将促进药物化学方案的实施。

Replacing high throughput biochemical screening for drug targets, with high throughput fragment screening (e.g. XChem methodology) followed by enhanced computational approaches to optimise fragment hits into leads, could accelerate projects and reduce costs and the requirement for large compound libraries. To achieve this high quality fragment libraries covering a broad chemical space must be developed. Fortunately, thousands of possible medicinal chemistry relevant heterocycles that would enrich fragment screening sets and be useful building blocks for medicinal chemistry campaigns are unreported.These novel heterocycles, knowledge of workable synthetic routes and the establishment of new synthetic methodology will facilitate the delivery of medicinal chemistry programmes.